Clinical Report: Efficacy and Safety of Recombinant Human BNP for Sepsis

Overview

This systematic review and meta-analysis evaluates the efficacy and safety of recombinant human brain natriuretic peptide (rhBNP) in treating sepsis complicated by heart failure (SCHF). The findings suggest that while rhBNP may reduce 28-day mortality and protect cardiac function, its clinical efficacy remains debated.

Background

Sepsis is a critical condition characterized by organ dysfunction due to an unregulated response to infection, with heart failure being a significant complication. Current treatments for septic cardiomyopathy, such as inotropic agents, often yield suboptimal results, highlighting the need for novel therapeutic options. Natriuretic peptides, particularly BNP, have emerged as potential biomarkers and therapeutic agents in this context.

Data Highlights

No numerical data available in the source material.

Key Findings

• Sepsis complicated by heart failure accounts for 18–65% of septic complications.
• Current inotropic treatments for septic cardiomyopathy have limited efficacy.
• Elevated BNP and NT-proBNP levels correlate with sepsis severity and mortality.
• Preclinical studies suggest rhBNP may reduce myocardial injury and mortality in septic models.
• Clinical studies show mixed results regarding rhBNP's impact on 28-day mortality.

Clinical Implications

Strengthen the emphasis on the need for further research and specify patient types for careful selection.

Conclusion

Reiterate the need for further investigation and specify focus areas for future research.

References

1. Ko et al., Critical Care, 2026 -- Early norepinephrine in septic shock: are we treating physiology or system efficiency?
2. Critical Care, 2025 -- The effects of vasopressor choice on renal outcomes in septic shock: a systematic review of randomised trials as a guide for future research
3. Critical Care, 2025 -- Sodium ascorbate versus ascorbic acid in sepsis: a narrative review of emerging cardiovascular and neurological benefits
4. Surviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock 2026 | SCCM
5. Sepsis-induced cardiomyopathy | European Heart Journal, 2023
6. Intensive Care Medicine — Review of Key Developments in Intensive Care Medicine for 2011: Focus on Cardiovascular Issues, Infections, Pneumonia, Sepsis, Critical Care Organization and Outcomes, Education, Ultrasonography, Metabolism, and Coagulation
7. Surviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock 2026 | SCCM
8. Sepsis-induced cardiomyopathy | European Heart Journal | Oxford Academic
9. Acute Study of Clinical Effectiveness of Nesiritide in Decompensated Heart Failure Trial - American College of Cardiology